PBLA - Panbela Therapeutics (PBLA) Stock Is Down 25%: What's Going On? | Benzinga
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading lower by 25% to $1.18 Wednesday afternoon, pulling back following recent, marked strength.
The company on Monday announced FDA approval of eflornithine, a drug they divested to US WorldMeds, for treating high-risk neuroblastoma patients who ...
PBLA) Stock Is Down 25%: What's Going On?>Full story available on Benzinga.com